1,2-distearoyllecithin has been researched along with Colorectal Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; Erdoğ, A; Keskin, D; Putra Limasale, YD; Tezcaner, A | 1 |
Franzen, U; Gammelgaard, B; Nguyen, TT; Ostergaard, J; Vermehren, C | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and Colorectal Cancer
Article | Year |
---|---|
In vitro characterization of a liposomal formulation of celecoxib containing 1,2-distearoyl-sn-glycero-3-phosphocholine, cholesterol, and polyethylene glycol and its functional effects against colorectal cancer cell lines.
Topics: Celecoxib; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Colorectal Neoplasms; Drug Delivery Systems; HCT116 Cells; HT29 Cells; Humans; Liposomes; Phosphatidylcholines; Polyethylene Glycols; Pyrazoles; Sulfonamides | 2013 |
Characterization of a liposome-based formulation of oxaliplatin using capillary electrophoresis: encapsulation and leakage.
Topics: Algorithms; Antineoplastic Agents; Colorectal Neoplasms; Drug Compounding; Drug Delivery Systems; Drug Stability; Electrophoresis, Capillary; Liposomes; Organoplatinum Compounds; Oxaliplatin; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylglycerols; Polyethylene Glycols; Solubility; Spectrophotometry, Atomic | 2011 |